American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Marpai, Inc. (MRAI)

$3.13 -1.11% OTC: MRAI · 15-min delayed

TAMPA, Florida
Public · OTC: MRAI

Visit website Follow

$18.1MRevenue · FY2025

-$16.6MNet income

MRAIOTC

About Marpai, Inc.

MARPAI INC A

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: MRAI
Headquarters: TAMPA, Florida
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: MRAI OTC
SEC CIK: 1844392
SIC: 8090 Services-Misc Health & Allied Services, NEC

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Marpai, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/marpai-inc/"><img src="https://americancompanies.com/badge/marpai-inc.svg" alt="Marpai, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Marpai, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $18.1M
Net income: -$16.6M
Total assets: $10.9M

Source: SEC EDGAR · updated Jun 7, 2026

OTC: MRAI

$3.13 -1.11%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.22 $4.11

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Marpai, Inc. (MRAI) Stock Price

Reported a net loss of $16.6M in FY2025.
Trading 24% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Marpai, Inc..

Write a review

Newsroom

News about Marpai, Inc.

Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 Benzinga · 2026-05-26 · positive MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Benzinga · 2026-05-15 · positive Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability Benzinga · 2026-05-11 · positive Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide Benzinga · 2026-04-01 · positive Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives Benzinga · 2026-03-09 · positive Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion Benzinga · 2026-02-23 · positive

News & sentiment via Polygon.io

FAQ

Marpai, Inc.: frequently asked questions

Is Marpai, Inc. an American company?

Marpai, Inc. is a US-based company headquartered in Tampa, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Marpai, Inc. headquartered?

Marpai, Inc. is headquartered in Tampa, Florida, United States.

Is Marpai, Inc. publicly traded?

Yes — Marpai, Inc. is a publicly traded company. Its stock trades under the ticker symbol MRAI on the OTC.

What does Marpai, Inc. do?

Marpai, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore